NEW YORK, June 20 - Large Scale Biology has expanded its business development team, creating two new executive positions, the company said Wednesday.
Pieter Bax, who joined LSBC earlier this year, will serve as senior vice president for corporate development, and Guy della-Cioppa, formerly vice president for genomics, will serve as vice president for business development.
In addition, Manfred Scholz recently joined the company as senior director for business development.
LSBC said in a statement that the new appointments were geared to drumming up awareness of the company's technology and to encouraging new partnerships.
Before joining LSBC, Bax served as vice president of the biopharmaceutical development division of SRI International, a consulting firm, and previously worked as vice president for business development and product planning at Corvas International, a biotechnology firm based in San Diego.
Della-Cioppa has served as vice president for genomics at LSBC since 1989. During his tenure, he managed LSBC's business relationship with Dow Chemical and Dow AgroSciences, and in his new business development position, he will focus on establishing new business alliances, the company said.
Scholz will be located at LSBC's proteomics facility in Germantown, Md. Prior to joining LSBC, he worked at Boston Medical Consultants, where he provided strategic planning and market forecasting for in vitro diagnostics, histopathology, SNP genotyping and other genomics and proteomics companies.